Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis, Ulcerative | 20 | 2024 | 1922 | 7.120 |
Why?
|
| Inflammatory Bowel Diseases | 12 | 2024 | 2419 | 3.260 |
Why?
|
| Pouchitis | 3 | 2022 | 64 | 2.310 |
Why?
|
| Colonic Pouches | 3 | 2023 | 122 | 2.260 |
Why?
|
| Piperidines | 6 | 2024 | 1656 | 2.240 |
Why?
|
| Proctocolectomy, Restorative | 3 | 2023 | 190 | 2.170 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 4 | 2024 | 285 | 1.900 |
Why?
|
| Tramadol | 2 | 2024 | 60 | 1.760 |
Why?
|
| Crohn Disease | 7 | 2024 | 2278 | 1.750 |
Why?
|
| Pyrimidines | 6 | 2024 | 3024 | 1.450 |
Why?
|
| Biological Products | 3 | 2024 | 911 | 1.390 |
Why?
|
| Analgesics, Opioid | 7 | 2024 | 3792 | 1.190 |
Why?
|
| Clostridium Infections | 3 | 2024 | 558 | 1.150 |
Why?
|
| Hospitals, Teaching | 2 | 2021 | 1155 | 1.020 |
Why?
|
| Gastrointestinal Agents | 4 | 2024 | 510 | 0.990 |
Why?
|
| Remission Induction | 6 | 2024 | 2394 | 0.830 |
Why?
|
| Carcinoma, Small Cell | 1 | 2023 | 420 | 0.750 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2020 | 370 | 0.570 |
Why?
|
| Cytomegalovirus Infections | 1 | 2023 | 831 | 0.550 |
Why?
|
| Cannabis | 1 | 2021 | 437 | 0.480 |
Why?
|
| Colectomy | 1 | 2019 | 687 | 0.460 |
Why?
|
| Treatment Outcome | 14 | 2024 | 64591 | 0.420 |
Why?
|
| Retrospective Studies | 14 | 2024 | 80430 | 0.370 |
Why?
|
| Helicobacter pylori | 1 | 2014 | 376 | 0.360 |
Why?
|
| Helicobacter Infections | 1 | 2014 | 385 | 0.360 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2014 | 269 | 0.360 |
Why?
|
| Adult | 20 | 2024 | 220781 | 0.330 |
Why?
|
| Necrosis | 2 | 2024 | 1604 | 0.330 |
Why?
|
| Humans | 40 | 2024 | 760437 | 0.320 |
Why?
|
| Pain | 2 | 2023 | 5075 | 0.320 |
Why?
|
| Stilbenes | 3 | 2015 | 155 | 0.320 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2024 | 4355 | 0.300 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2014 | 611 | 0.300 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3576 | 0.290 |
Why?
|
| Myocardial Ischemia | 5 | 2017 | 2110 | 0.290 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3777 | 0.280 |
Why?
|
| Postoperative Complications | 3 | 2019 | 15627 | 0.270 |
Why?
|
| Immunoconjugates | 1 | 2014 | 953 | 0.270 |
Why?
|
| Treatment Failure | 2 | 2024 | 2642 | 0.270 |
Why?
|
| Colonoscopy | 3 | 2024 | 1392 | 0.270 |
Why?
|
| Hospitals | 1 | 2019 | 3873 | 0.260 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 15820 | 0.260 |
Why?
|
| Antirheumatic Agents | 1 | 2014 | 1371 | 0.240 |
Why?
|
| DNA Damage | 1 | 2014 | 2441 | 0.230 |
Why?
|
| Stomach Neoplasms | 1 | 2014 | 1428 | 0.230 |
Why?
|
| Codeine | 1 | 2023 | 51 | 0.220 |
Why?
|
| Myocardium | 5 | 2017 | 4700 | 0.210 |
Why?
|
| Biological Factors | 1 | 2024 | 157 | 0.210 |
Why?
|
| Excipients | 1 | 2023 | 98 | 0.210 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 9410 | 0.200 |
Why?
|
| Denmark | 1 | 2024 | 766 | 0.200 |
Why?
|
| Cohort Studies | 5 | 2024 | 41366 | 0.190 |
Why?
|
| Morphine Derivatives | 1 | 2021 | 42 | 0.190 |
Why?
|
| Anal Canal | 1 | 2023 | 373 | 0.180 |
Why?
|
| Middle Aged | 12 | 2024 | 220382 | 0.180 |
Why?
|
| Medical Illustration | 1 | 2021 | 135 | 0.170 |
Why?
|
| Anastomosis, Surgical | 1 | 2023 | 983 | 0.170 |
Why?
|
| Arthralgia | 1 | 2024 | 463 | 0.170 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2015 | 1094 | 0.170 |
Why?
|
| Acetaminophen | 1 | 2023 | 554 | 0.160 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2014 | 3759 | 0.160 |
Why?
|
| Male | 18 | 2024 | 360035 | 0.160 |
Why?
|
| Rectum | 1 | 2023 | 892 | 0.160 |
Why?
|
| Pennsylvania | 1 | 2019 | 613 | 0.150 |
Why?
|
| Female | 14 | 2024 | 391875 | 0.150 |
Why?
|
| Patient Discharge | 2 | 2021 | 3436 | 0.140 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 5126 | 0.140 |
Why?
|
| Analgesics | 1 | 2023 | 1070 | 0.140 |
Why?
|
| Length of Stay | 2 | 2020 | 6413 | 0.130 |
Why?
|
| Sternotomy | 1 | 2017 | 128 | 0.130 |
Why?
|
| United States | 4 | 2024 | 72202 | 0.130 |
Why?
|
| Alcoholic Beverages | 1 | 2017 | 264 | 0.120 |
Why?
|
| Polyenes | 1 | 2015 | 68 | 0.120 |
Why?
|
| Drug Monitoring | 1 | 2021 | 961 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 15867 | 0.120 |
Why?
|
| Ascomycota | 1 | 2015 | 81 | 0.120 |
Why?
|
| Perception | 1 | 2021 | 1196 | 0.120 |
Why?
|
| Drug Prescriptions | 1 | 2023 | 1669 | 0.110 |
Why?
|
| Propensity Score | 1 | 2021 | 1906 | 0.110 |
Why?
|
| Pain, Postoperative | 1 | 2024 | 1736 | 0.110 |
Why?
|
| Aftercare | 1 | 2019 | 911 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 2272 | 0.110 |
Why?
|
| Acute Disease | 1 | 2024 | 7230 | 0.110 |
Why?
|
| Young Adult | 4 | 2024 | 59068 | 0.110 |
Why?
|
| Colon | 1 | 2021 | 1791 | 0.100 |
Why?
|
| Heptanoic Acids | 1 | 2014 | 344 | 0.100 |
Why?
|
| Pericardium | 1 | 2017 | 675 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 1874 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 17854 | 0.100 |
Why?
|
| ROC Curve | 1 | 2019 | 3571 | 0.100 |
Why?
|
| Recurrence | 1 | 2024 | 8466 | 0.100 |
Why?
|
| Plant Extracts | 1 | 2015 | 497 | 0.090 |
Why?
|
| Ethanol | 1 | 2017 | 1324 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2024 | 39078 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 787 | 0.090 |
Why?
|
| Cardiotonic Agents | 1 | 2013 | 539 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2014 | 1832 | 0.080 |
Why?
|
| Linear Models | 1 | 2019 | 5865 | 0.080 |
Why?
|
| Aged | 5 | 2024 | 168840 | 0.080 |
Why?
|
| Inpatients | 1 | 2021 | 2545 | 0.080 |
Why?
|
| Vaccination | 1 | 2021 | 3375 | 0.080 |
Why?
|
| Pyrroles | 1 | 2014 | 1126 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 5662 | 0.080 |
Why?
|
| Swine | 5 | 2017 | 5915 | 0.070 |
Why?
|
| Sepsis | 1 | 2021 | 2583 | 0.070 |
Why?
|
| Patient Readmission | 1 | 2020 | 3249 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 12054 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2021 | 4316 | 0.070 |
Why?
|
| Autophagy | 1 | 2013 | 1319 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2019 | 5283 | 0.060 |
Why?
|
| Adolescent | 3 | 2024 | 88196 | 0.060 |
Why?
|
| Inflammation | 2 | 2015 | 10746 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2019 | 7948 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2021 | 54339 | 0.060 |
Why?
|
| Cholesterol, Dietary | 2 | 2015 | 224 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 3609 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 15257 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9267 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5663 | 0.050 |
Why?
|
| Swine, Miniature | 2 | 2014 | 961 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2015 | 23397 | 0.050 |
Why?
|
| Heart | 1 | 2015 | 4391 | 0.050 |
Why?
|
| Apoptosis | 2 | 2014 | 9468 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2014 | 3975 | 0.040 |
Why?
|
| Proteins | 1 | 2015 | 6033 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3243 | 0.040 |
Why?
|
| Disease Models, Animal | 5 | 2017 | 18216 | 0.040 |
Why?
|
| Insulin | 1 | 2013 | 6591 | 0.040 |
Why?
|
| Quality of Life | 1 | 2019 | 13338 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2014 | 5031 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 2017 | 218 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2021 | 871 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 58859 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2015 | 352 | 0.030 |
Why?
|
| Genome, Fungal | 1 | 2015 | 203 | 0.030 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2013 | 53 | 0.030 |
Why?
|
| DNA, Fungal | 1 | 2015 | 275 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2013 | 100 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2014 | 282 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2015 | 393 | 0.030 |
Why?
|
| Phytotherapy | 1 | 2015 | 296 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2014 | 729 | 0.030 |
Why?
|
| Risk Factors | 1 | 2019 | 74055 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2024 | 10759 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2024 | 8522 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 597 | 0.020 |
Why?
|
| Cell Death | 1 | 2015 | 1664 | 0.020 |
Why?
|
| Opioid-Related Disorders | 1 | 2024 | 2152 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2017 | 4010 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 1075 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 1135 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 1485 | 0.020 |
Why?
|
| Age Factors | 1 | 2024 | 18379 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2024 | 9176 | 0.020 |
Why?
|
| Antioxidants | 1 | 2015 | 1670 | 0.020 |
Why?
|
| Animals | 5 | 2017 | 168253 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 2058 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 2642 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 4735 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2015 | 3088 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2013 | 8311 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 17639 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2015 | 3405 | 0.010 |
Why?
|
| Mitochondria | 1 | 2015 | 3624 | 0.010 |
Why?
|
| Proteomics | 1 | 2015 | 3818 | 0.010 |
Why?
|
| Glucose | 1 | 2013 | 4342 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2014 | 9309 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 13484 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 39947 | 0.010 |
Why?
|
Concepts
(169)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_